These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11365480)

  • 21. Post-exposure prevention (PEP) for sexual, needle exposure opens in New York.
    AIDS Treat News; 2000 Jan; (No 335):6-7. PubMed ID: 11367204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature.
    Rossero R; Asmuth DM; Grady JJ; McKinsey DS; Green S; Andron L; Pollard RB
    Int J STD AIDS; 2003 May; 14(5):350-5. PubMed ID: 12803944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus postexposure prophylaxis for adolescents and children.
    Merchant RC; Keshavarz R
    Pediatrics; 2001 Aug; 108(2):E38. PubMed ID: 11483848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Revised guideline "Antiretroviral Treatment"].
    Werkgroep antiretrovirale behandeling van de Nederlandse Vereniging van Aids Behandelaren
    Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2399-405. PubMed ID: 16277129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Post-exposure prophylaxis following exposure to HIV: adaptation to the situation may be indicated].
    Wensing AM; Schneider MM; Schurink CA; Geerlings SE; Boucher CA
    Ned Tijdschr Geneeskd; 2005 Jul; 149(27):1485-9. PubMed ID: 16032990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Updated postexposure guidelines stress need for expert advice.
    AIDS Alert; 1998 Jul; 13(7):73-5. PubMed ID: 11365585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HIV post exposure prophylaxis therapy - the experience of two major AIDS centers].
    Elbirt D; Levy I; Asher I; Mahlev-Guri K; Rosenberg-Bezalet S; Litachevsky S; Radian-Sade S; Sthoeger Z
    Harefuah; 2013 Apr; 152(4):224-9, 246. PubMed ID: 23844525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Piloting post-exposure prophylaxis in Kenya raises specific concerns for the management of childhood rape.
    Speight CG; Klufio A; Kilonzo SN; Mbugua C; Kuria E; Bunn JE; Taegtmeyer M
    Trans R Soc Trop Med Hyg; 2006 Jan; 100(1):14-8. PubMed ID: 16225898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients.
    Llibre JM; Domingo P; del Pozo MA; Miralles C; Galindo MJ; Viciana I; Moreno S; Schapiro JM; Clotet B
    J Antimicrob Chemother; 2008 Jan; 61(1):206-9. PubMed ID: 17999972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylaxis of HIV infection.
    Omrani AS; Freedman A
    Br Med Bull; 2005; 73-74():93-105. PubMed ID: 16207801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Post-exposure prophylaxis of HIV infection in out-patient clinic of hospital for infectious diseases in Warsaw in 2001-2002].
    Kowalska JD; Firlag-Burkacka E; Niezabitowska M; Bakowska E; Ignatowska A; Pulik P; Horban A
    Przegl Epidemiol; 2006; 60(4):789-94. PubMed ID: 17682761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV post-exposure prophylaxis provided at an urban paediatric emergency department to female adolescents after sexual assault.
    Merchant RC; Keshavarz R; Low C
    Emerg Med J; 2004 Jul; 21(4):449-51. PubMed ID: 15208228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of antiretroviral chemoprophylaxis after occupational HIV exposure].
    Madsen KM; Gerstoft J; Kvinesdal BB; Nielsen HI; Møller A; Pedersen C; Obel N
    Ugeskr Laeger; 1999 Nov; 161(48):6619-21. PubMed ID: 10643345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals.
    Duvivier C; Myrto A; Marcelin AG; Ghosn J; Ait-Mohand H; Schneider L; Agher R; Bricaire F; Costagliola D; Calvez V; Peytavin G; Katlama C
    Antivir Ther; 2003 Dec; 8(6):603-9. PubMed ID: 14760894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidelines for post-exposure treatment not likely soon.
    AIDS Policy Law; 1997 Aug; 12(15):4-5. PubMed ID: 11364600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotypic resistance tests for the management of postexposure prophylaxis.
    Puro V
    Scand J Infect Dis Suppl; 2003; 106():93-8. PubMed ID: 15000596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proposed recommendations for the management of HIV post-exposure prophylaxis after sexual, injecting drug or other exposures in Europe.
    Almeda J; Casabona J; Simon B; Gerard M; Rey D; Puro V; Thomas T;
    Euro Surveill; 2004 Jun; 9(6):35-40. PubMed ID: 15223890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AVANTI 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients.
    Gartland M;
    Antivir Ther; 2001 Jun; 6(2):127-34. PubMed ID: 11491417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.